Association of a Trp16Ser variation in the gonadotropin releasing hormone signal peptide with bone mineral density, revealed by SNP-dependent PCR typing

Bone

Volumn 32, Issue 2, 2003, Pages 185-190

  Iwasaki, Hironori ^a   Emi, Mitsuru ^a   Ezura, Yoichi ^a   Ishida, Ryota ^a   Kajita, Mitsuko ^a   Kodaira, Mina ^a   Yoshida, Hideyo ^b   Suzuki, Takao ^b   Hosoi, Takayuki ^b   Inoue, Satoshi ^c   Shiraki, Masataka ^d   Swensen, Jeff ^e   Orimo, Hajime ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Res Inst Pract Involutional Dis   (Japan)

^e Myriad Genetic Laboratories   (United States)

Author keywords

Association study; Bone mineral density; GnRH; Quantitative trait; Single nucleotide polymorphism

Indexed keywords

ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0037292521     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00949-3     Document Type: Article

References (23)

1. Giguere Y., Rousseau F. The genetics of osteoporosis 'complexities and difficulties.' . Clin Genet. 57:2000;161-169.
2. Stewart T.L., Ralston S.H. Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol. 166:2000;235-245.
3. Armamento-Villareal R., Villareal D.T., Avioli L.V., Civitelli R. Estrogen status and heredity are major determinants of premenopausal bone mass. J Clin Invest. 90:1992;2464-2471.
4. Khosla S., Atkinson E.J., Melton L.J. 3rd, Rigg B.L. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women a population-based study . J Clin Endocrinol Metab. 82:1997;1522-1527.
5. Riggs B.L., Melton L.J. 3rd. Involutional osteoporosis. N Engl J Med. 314:1986;1676-1686.
6. Christiansen C., Christiansen M.S. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet. 2:1981;459-461.
7. Felson D.T., Zhang Y., Hannan M.T., Kiel D.P., Wilson P.W., Anderson J.J. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 329:1993;1141-1146.
8. Herbison A.E., Pape J.R. New evidence for estrogen receptors in gonadotropin-releasing hormone neurons. Front Neuroendocrinol. 22:2001;292-308.
9. Kang S.K., Choi K.C., Tai C.J., Auersperg N., Leung P.C. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells. Endocrinology. 142:2001;580-588.
10. Seminara S.B., Hayes F.J., Crowley W.F. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome) pathophysiological and genetic considerations . Endocr Rev. 19:1998;521-539.
11. Aono T., Kinugasa T., Yamamoto T., Miyake A., Kurachi K. Assessment of gonadotropin secretion in women with anorexia nervosa. Acta Endocinol. 80:1975;630.
12. Rust S., Funke H., Assmann G. Mutagenically separated PCR (MS-PCR) a highly specific one step procedure for easy mutation detection . Nucleic Acids Res. 21:1993;3623-3629.
13. Kleinbaum D.G., Kupper L.L., Muller K.E. Applied regression analysis and other multivariate methods. 2nd ed :1988;299-301 PWS-KENT, Boston.
14. Orimo H., Hayashi Y., Fukunaga M., Sone T., Fujiwara M., Shiraki M., Kushida K., Miyamoto S., Soen S., Nishimura J., Oh-hashi Y., Hosoi T., Gorai I., Tanaka H., Igai T., Kishimoto H. Diagnostic criteria for primary osteoporosis year 2000 revision . J Bone Miner Metab. 19:2001;331-337.
15. Ogawa S., Hosoi T., Shiraki M., Orimo H., Emi M., Muramatsu M., Ouchi Y., Inoue S. Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun. 269:2000;537-541.
16. Goulding A., Fisher L. 17 beta-estradiol protects rats from osteopenia associated with administration of the luteinising hormone releasing hormone (LHRH) agonist, buserelin. Bone Miner. 13:1991;47-53.
17. Rico H., Arnanz F., Revilla M., Perera S., Iritia M., Villa L.F., Arribas I. Total and regional bone mineral content in women treated with GnRH agonists. Calcif Tissue Int. 52:1993;354-357.
18. Shaw R.W. A risk benefit assessment of drugs used in the treatment of endometriosis. Drug Saf. 11:1994;104-113.
19. Karaplis A.C., Lim S.K., Baba H., Arnold A., Kronenberg H.M. Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein. J Biol Chem. 270:1995;1629-1635.
20. Nakajima T., Cheng T., Rohrwasser A., Bloem L.J., Pratt J.H., Inoue I., Lalouel J.M. Functional analysis of a mutation occurring between the two in-frame AUG codons of human angiotensinogen. J Biol Chem. 274:1999;35749-35755.
21. Seppen J., Steenken E., Lindhout D., Bosma P.J., Elferink R.P. A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett. 390:1996;294-298.
22. Shimoda M.S., Mtsumine H., Kobayashi T., Nakagawa H.Y., Shimizu Y., Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun. 226:1996;561-565.
23. Martoglio B., Dobberstein B. Signal sequences more than just greasy pepides . Trends Cell Biol. 8:1998;410-415.